Atum
ATUM (formerly DNA2.0) offers an integrated pipeline of solutions including gene design, optimization and synthesis, technology platforms for protein and strain engineering and protein expression.
Members
IGSC member directory
Blue Heron
Blue Heron Biotech LLC is a member of the Eurofins Group. Blue Heron’s proprietary Genemaker® Technology platform makes us the true experts in custom DNA design and gene synthesis.
DAMP Lab
The DAMP lab, a cloud laboratory located at Boston University, supports synthetic biology-related activities by creating novel biological systems using a combination of liquid handling robotics, standardized protocols, and computerized software scheduling.
GenScript
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to make people and nature healthier through biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,000 employees and has served more than 200,000 customers across 100 countries.
Ginkgo Bioworks
Ginkgo Bioworks uses the most advanced technology on the planet–biology–to grow products instead of manufacture them. The company’s technology platform is bringing biotechnology into consumer goods markets enabling companies to make better products. In early 2017 Ginkgo acquired Gen9 and has since integrated the company’s DNA synthesis expertise into its foundries to accelerate organism engineering.
IDT
IDT specializes in DNA synthesis, gene construction, antisense oligos, molecular beacons and a variety of molecular biology products.
Telesis Bio
Telesis Bio empowers researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA. Creators of the BioXp™ system, the world’s only synthetic biology workstation, and the industry-standard Gibson Assembly® method, Telesis Bio accelerates advances in the fields of personalized medicine, antibody engineering, vaccine development, biologics drug discovery, and more.
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer.
Twist Bioscience
At Twist Bioscience, we work in service of people who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, our unique silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers.
4basebio
4basebio is a Cambridge-based biotechnology company pioneering the use of synthetic DNA to enable next-generation therapeutics and vaccines. Through its proprietary enzymatic DNA synthesis platform, 4basebio produces GMP-grade synthetic DNA with superior speed, purity, and scalability, overcoming the limitations of plasmid-based systems. The company offers application-specific DNA constructs tailored to the diverse needs of gene therapies, genome editing, mRNA production, and DNA vaccines. These solutions help partners accelerate proof-of-concept studies and reach clinical milestones more efficiently, while maintaining the highest standards of safety and quality. With a focus on innovation, flexibility, and precision, 4basebio equips biopharma and academic partners with the tools to unlock the full potential of genetic medicine.
Aclid
Aclid was founded to advance responsible research in synthetic biology. The company's platform is an end-to-end solution for screening DNA sequences and customers.
Agilent
Agilent Technologies is a global leader in the life sciences, diagnostics, and applied markets, delivering insight and innovation that advance the quality of life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions.
Aldevron
Aldevron is a premier manufacturing partner in the global genetic medicine field. Founded in 1998 by Michael Chambers and John Ballantyne, the company provides critical nucleic acids and proteins used to make gene and cell therapies, DNA and RNA vaccines, and gene editing technologies. Aldevron’s 600 employees support thousands of scientists who are developing revolutionary treatments for millions of people.
Ansa Biotechnologies
Ansa Biotechnologies combines unique approaches to oligo synthesis and DNA assembly to make DNA in a new way that is faster and more robust than existing methods. Ansa's enzyme-based platform promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Artis BioSolutions
Artis provides fully integrated services with disciplined, end-to-end execution to accelerate advanced therapy medicinal products (ATMPs) from synthetic DNA through GMP manufacturing, all within a single quality framework. Our model eliminates the handoffs, vendor transitions, and knowledge loss that slows programs down.
Azenta Life Sciences
Azenta Life Sciences, formerly GENEWIZ, leads the way in providing cold-chain sample management solutions and sample analysis and multiomics services including Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services. Our integrated portfolio enables researchers across areas such as drug development, clinical research, and advanced cell therapies to advance their scientific discoveries faster, with greater confidence, and with a trusted partner by their side. Azenta Life Sciences is headquartered in Massachusetts, with operations in North America, Europe and Asia.
Battelle
Battelle is the world’s largest independent, non-profit research and development organization, founded to translate scientific and technological advancements into societal benefits. The company’s business spans areas that encompass risk-reduction, security solutions, and technology enablement. Recognizing the emerging complexity and scale of gene synthesis, Battelle developed ThreatSEQ™ services, a web-based, continuously-curated DNA screening platform for the detection, characterization, and threat assessment of sequences of concern.
BGI
With a goal of making state-of-the-art genomics highly accessible to the global research community and clinical markets, BGI has integrated the industry’s broadest array of leading technologies, including high-throughput, cost-effective sequencing and synthesis platform, large sample collection and storage, and expert bioinformatics resources, to offer a wide service portfolio around the world.
Biolytic Lab Performance, Inc.
Biolytic Lab Performance, Inc. designs and manufactures cutting-edge DNA and RNA oligo synthesizers. Biolytic offers comprehensive oligonucleotide synthesis solutions, including consumables, Dr. Oligo DNA RNA oligo synthesizers, accessories, and instrument services, with a commitment to innovation, efficiency, and quality. Headquartered in Fremont, CA, Biolytic serves biotech labs worldwide, leveraging over 30 years of industry experience.
Bioneer Corp.
Bioneer Corp., an innovative genomics platform company, pioneers the next generation high performance and rapid automation in delivering cost-efficient total genomics solution.
BUILT
BUILT Biotechnologies bridges the gap between DNA synthesis and ready-to-use DNA molecules, completing the 'last mile' of the DNA supply chain. Through its centralized, subscription-based DNA Manufacturing-as-a-Service platform, BUILT provides the biotech industry with specialized expertise in building long and complex DNA constructs that are often deemed 'unbuildable,' offering unparalleled capability, reliability, and speed. By streamlining access to Fully BUILT DNA™, BUILT empowers customers to eliminate in-house assembly, accelerate research timelines, and reduce costs.
Camena Bioscience
Camena Bioscience has developed a highly accurate DNA and gene synthesis technology. Our mission is to enable synthetic biologists by providing access to genes produced with unparalleled accuracy.
Constructive Bio
Constructive Bio develops technologies for wholesale genome synthesis and genetic code expansion, turning cells into programmable biofactories to produce complex, valuable molecules at scale. By adding new chemistries to the repertoire of living cells, Constructive drives the sustainable bioproduction of the next generation of biopharmaceuticals.
Cyber@Ben-Gurion University of the Negev
Cyber@BGU is at the forefront of security, big data analytics, and AI applied research at Ben-Gurion University. Nestled in the heart of Beer Sheva’s Hi-Tech park—Israel’s Cyber Capital—our state-of-the-art R&D center is a beacon for pioneering projects. In collaboration with industrial and governmental allies, CBG continually strives to drive innovation and tackle the most pressing technological security challenges.
DNA Script
DNA Script was created to revolutionize DNA write with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM, the world’s first benchtop DNA printer powered by enzymatic technology.
Edinburgh Genome Foundry
The Edinburgh Genome Foundry specialises in the computer-aided-design and automated assembly of large DNA constructs up to chromosome size.
Elegen Bio
Elegen is bringing unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences. The company is led by seasoned leaders with decades of experience in developing novel and scalable approaches in molecular biology, chemistry, and microfluidics. Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare, and pharma industries. Founded in 2017, Elegen is privately held and based in the San Francisco Bay Area.
Emerald Cloud Lab
Emerald Cloud Lab provides researchers with remote access to state-of-the-art scientific labs from anywhere on earth, 24 hours a day, 365 days per year. With ECL researchers utilize a single software interface to securely design, run, and analyze experiments, allowing researchers to spend more time designing protocols and analyzing data, and less time on mundane time-intensive activities in the lab.
GP-Write
Genome Project-write (GP-write) is an open, international consortium, formed as a sequel to the Human Genome Project (HGP-read), and led by a multi-disciplinary group of scientific leaders. The overarching goal is to oversee a reduction in the cost of engineering and testing large genomes in cell lines more than 1,000-fold over the next decade through scientific and technological initiatives. GP-write technology has launched with a whole genome software design platform as a foundational technology in its emergent international foundry and start-up ecosystem.
IBBIS
IBBIS is a Geneva-based nonprofit that works collaboratively with global partners to strengthen biosecurity norms and develop innovative tools to uphold them.
LatchBio
LatchBio researches and builds agents across domains in biology and Latch is creating the AI infrastructure for biosecurity.
Levostar Biotech
Levostar Biotech is a technology-driven biotechnology company dedicated to advancing next-generation in vivo CAR-T and advanced cell and gene therapies through mRNA–LNP–based engineering solutions. By leveraging our proprietary mRNA synthesis platform, targeted lipid nanoparticle (tLNP) delivery technology, and in vivo CAR-T characterization systems, we provide end-to-end services spanning DNA design, RNA production, in vivo delivery, and functional validation. Our integrated platform enables precise and efficient in vivo T cell engineering, accelerating the development and clinical translation of next-generation cell therapies. In addition to in vivo CAR-T solutions, Levostar Biotech applies synthetic biology, next-generation sequencing, and gene editing technologies to deliver innovative solutions for antibody discovery, cell and gene therapies, and RNA-based therapeutics. Levostar Biotech operates globally, with teams and operations in China and the United States, supporting biopharmaceutical partners worldwide in bringing transformative therapies to patients.
Microsynth
Microsynth provides custom DNA and RNA oligonucleotides, sequencing and molecular analysis services for research, diagnostics and biotechnology. With a broad portfolio of modifications and scalable synthesis solutions, the company supports gene synthesis and synthetic biology workflows—from oligonucleotide building blocks to the verification of completed DNA constructs.
MITRE
As a not-for-profit organization, MITRE acts in the public interest by delivering objective, cost-effective solutions to many of the world's biggest challenges. We operate FFRDCs—federally funded research and development centers—and provide technical expertise, stability, and continuity to government agency sponsors. Through our work we power advances in national defense, aviation safety, biosecurity, financial systems, healthcare, cybersecurity, and more—advances that make your life better. In biotechnology, we seek to deliver transformational capabilities through the rapid identification, exploration, and maturation of emerging biotechnologies to solve the nation’s hardest problems. This includes defining new program activities, supporting test and evaluation, identifying technology trends, performing research and development, and developing holistic, integrated solutions across multiple mission domains.
nagene
nagene GmbH is a Vienna-based biotechnology company specializing in de novo gene synthesis and advanced DNA construct development. We focus on complex and high-quality synthetic DNA solutions for applications in gene therapy, mRNA, and synthetic biology. Our in-house production enables fast turnaround times while maintaining high quality standards under an ISO 9001-certified quality management system. We are currently preparing for GMP certification and have already implemented key processes aligned with regulatory expectations for advanced therapeutic applications. As an emerging provider, we are committed to responsible innovation, biosecurity, and alignment with international standards.
NunaBio
NunaBio is redefining DNA manufacturing through a fully integrated approach that enables more complex DNA to be made at scale today, helping open the door to new therapeutics for patients and a more accessible, secure and deployable model for DNA supply.
Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry, with a product portfolio of over 4,000 products supporting a range of life science work in cell biology, DNA, RNA and protein analysis, drug development, human identification and molecular diagnostics.
Ribbon Bio
We are redefining scientific possibility with our algorithm-driven technology that produces pristine synthetic DNA molecules, enabling our partners to deliver a new generation of transformative solutions for the health of people and planet.
RTX BBN Technologies
RTX BBN Technologies delivers cutting-edge solutions that detect and identify known, emerging and engineered biological threats. BBN offers the FAST-NA nucleic acid screening tool and advances global standards and harmonization to address the growing complexity of the biosecurity landscape.
Safely.bio
Safely.bio builds customer-verification (KYC) software for DNA synthesis providers. Our software integrates directly into order intake to confirm the identity and legitimacy of customers. Founded by Phil Palmer and Joey Bream, safely.bio's mission is to make robust, low-cost customer screening standard across the synthesis industry.
Synbio Technologies
Synbio Technologies, is a full-service provider of advanced synthetic biology products and services. The company specializes in the development of innovative technology platforms for industrial biotechnology applications. They offer a wide range of services including gene synthesis and engineering, protein design and optimization, custom library construction, gene expression testing and analysis, bioinformatics consulting services, product formulation, and manufacturing support. With their dedicated team of experts and progressive DNA technologies, Synbio Technologies enables researchers, scientists, synthetic biologists, and drug developers to push the boundaries of what is possible in the life sciences.
Synplogen
Synplogen is a DNA synthesis company spun out of Kobe University. Combining its proprietary OGAB techniques with cutting edge genetic engineering, information science and robotics, Synplogen provides a variety of services including DNA synthesis, DNA library development and viral vector development for gene therapy applications.
Touchlight
Touchlight is a privately-owned company based in London, U.K., focused on the provision of DNA services and manufacture of enzymatically produced novel DNA formats, such as doggybone DNA (dbDNA™) to enable the development of genetic medicines. Touchlight provides enzymatic DNA development and manufacturing, from research to GMP grade, for advanced therapy production, in a wide range of modalities including mRNA, viral and non-viral gene therapy and DNA vaccines. dbDNA™ is a linear, double-stranded, covalently closed DNA vector which eliminates bacterial sequences, including antibiotic resistance genes.
Tsingke Biotechnology Co., Ltd.
Tsingke covers the whole industry chain of gene synthesis, from equipment to raw materials. Based on the high-throughput synthesis platform, Tsingke provides a wide range of services including gene synthesis and modified oligos as well as molecular reagents.
Contact Us
Interested in becoming a member of the International Gene Synthesis Consortium?
Contact the IGSC at info@genesynthesisconsortium.org.